Home
Akebia Therapeutics AKBA spent $310K on lobbying in Q2 2023 · Health Issues, Medicare
Trade details
- Type
- Lobbying report
- Amount
- $310,000
- Quarter
- Q2 2023
- Client
- Akebia Therapeutics
- Reported
- 23/07/20
Up 0.0% from last quarter
What else happened in Akebia Therapeutics around then
Filed or reported within 30 days of the trade day · 23/05/31~23/07/30Akebia Therapeutics's other lobbying reports
- Akebia Therapeutics
LobbyingAkebia Therapeutics
LobbyingAkebia Therapeutics
AKBA
$360K
$360K
Reported 07/20
for Q2
- Akebia Therapeutics
LobbyingAkebia Therapeutics
LobbyingAkebia Therapeutics
AKBA
$60K
$60K
Reported 07/20
for Q2
- Akebia Therapeutics
LobbyingAkebia Therapeutics
LobbyingAkebia Therapeutics
AKBA
$60K
$60K
Reported 07/13
for Q2
- Akebia Therapeutics
LobbyingAkebia Therapeutics
LobbyingAkebia Therapeutics
AKBA
$480K
$480K
Reported 04/20
for Q1
- Akebia Therapeutics
LobbyingAkebia Therapeutics
LobbyingAkebia Therapeutics
AKBA
$60K
$60K
Reported 04/20
for Q1